BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1080753)

  • 1. Rejection of tumor cells in vitro: a T-cell-mediated reaction.
    Berczi I; Sehon AH
    Int J Cancer; 1975 Oct; 16(4):665-74. PubMed ID: 1080753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Oct; 16(4):539-49. PubMed ID: 1080750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
    Pollack SB; Nelson K
    Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Aug; 16(2):292-300. PubMed ID: 1150355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressor T cells in tumor bearing host.
    Fujimoto S; Greene M; Sehon AH
    Immunol Commun; 1975; 4(3):201-17. PubMed ID: 1080741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor-cell cytolysis.
    Leclerc JC; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Mar; 11(2):426-32. PubMed ID: 4545387
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-tumour cytotoxic effects mediated by minor and major cell populations of lymph nodes.
    Seeger RC; Owen JJ
    Nature; 1974 Nov; 252(5482):420-1. PubMed ID: 4547827
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated cytotoxicity to moloney sarcoma in syngeneic and allogeneic rats.
    Veit BC; Feldman JD
    Int J Cancer; 1975 Mar; 15(3):367-76. PubMed ID: 1079791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosette formation by guinea pig thymocytes and thymus derived lymphocytes with rabbit red blood cells.
    Stadecker MJ; Bishop G; Wortis HH
    J Immunol; 1973 Dec; 111(6):1834-7. PubMed ID: 4201559
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
    Evans R
    Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
    Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
    Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells.
    Lamon EW; Wigzell H
    Transplantation; 1974 Oct; 18(4):368-71. PubMed ID: 4547517
    [No Abstract]   [Full Text] [Related]  

  • 19. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell cytotoxicity and amplification of the cytotoxic reaction by macrophages.
    Lohmann-Matthes ML; Fischer H
    Transplant Rev; 1973; 17(0):150-71. PubMed ID: 4600484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.